Renal tubular transport protein regulation in primary aldosteronism: can large-scale proteomic analysis offer a new insight?

Affiliations

¹ 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. konvstavropoulos@hotmail.com.
² Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Comment

Konstantinos Stavropoulos et al. J Hum Hypertens. 2021 Oct.

. 2021 Oct;35(10):825-827.

doi: 10.1038/s41371-021-00537-0. Epub 2021 Apr 9.

¹ 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. konvstavropoulos@hotmail.com.
² Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
³ 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

No abstract available

Comment on

The Cl^-/HCO₃^- exchanger pendrin is downregulated during oral co-administration of exogenous mineralocorticoid and KCl in patients with primary aldosteronism.
Wu A, Wolley MJ, Wu Q, Gordon RD, Fenton RA, Stowasser M. Wu A, et al. J Hum Hypertens. 2021 Oct;35(10):837-848. doi: 10.1038/s41371-020-00439-7. Epub 2020 Nov 10. J Hum Hypertens. 2021. PMID: 33173144

1. Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:3–17. - PubMed
1. Stavropoulos K, Imprialos K, Papademetriou V, Faselis C, Tsioufis K, Dimitriadis K, et al. Primary aldosteronism: novel insights. Curr Hypertens Rev. 2020;16:19–23. - DOI
1. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889–916. - DOI
1. Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008;371:1921–6. - DOI
1. Monticone S, D’Ascenzo F, Moretti C, Williams TA, Veglio F, Gaita F, et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2018;6:42–50. - DOI